首页> 外文期刊>海南医科大学学报(英文版) >Effect of nutritional support + intravenous chemotherapy on anti-tumor immunity and cancer cell proliferation in patients with colon cancer complicated by incomplete intestinal obstruction
【24h】

Effect of nutritional support + intravenous chemotherapy on anti-tumor immunity and cancer cell proliferation in patients with colon cancer complicated by incomplete intestinal obstruction

机译:营养支持+静脉化疗对结肠癌合并肠梗阻不全患者抗肿瘤免疫和癌细胞增殖的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Objective:To study the effect of nutritional support + intravenous chemotherapy on anti-tumor immunity and cancer cell proliferation in patients with colon cancer complicated by incomplete intestinal obstruction.Methods: Patients with colon cancer complicated by incomplete intestinal obstruction who were treated in Midi Branch, Pangang Group General Hospital between March 2015 and October 2017 were selected and randomly divided into the nutrition group who accepted nutritional support + FOLFOX4 intravenous chemotherapy and the control group who accepted FOLFOX4 intravenous chemotherapy alone, and they underwent surgery after two cycles of chemotherapy. The contents of immune cells in peripheral blood and the contents of immune cytokines in serum were determined before chemotherapy and two cycles after chemotherapy; the expression levels of proliferation genes in colon cancer lesions were determined after surgical resection.Results:Compared with those of same group before chemotherapy, peripheral blood Treg, Th9, Th17 and Th22 contents as well as serum IL-4, IL-9, IL-10, TGF-β1, IL-17 and IL-22 contents of nutrition group were decreased significantly after chemotherapywhereas peripheral blood Treg, Th9, Th17 and Th22 contents as well as serum IL-4, IL-9, IL-10, TGF-β1, IL-17 and IL-22 contents of control group did not change significantly after chemotherapy, and compared with those after chemotherapy between groups, peripheral blood Treg, Th9, Th17 and Th22 contents as well as serum IL-4, IL-9, IL-10, TGF-β1, IL-17 and IL-22 contents of nutrition group were significantly lower than those of control group, and CyclinD1, Bcl-2, USP22, VEGF and N-cadherin mRNA expression were not different from those of control group.Conclusion:Nutritional support + intravenous chemotherapy can improve the anti-tumor immune response without affecting the proliferation of cancer cells in the lesion of patients with colon cancer complicated by incomplete intestinal obstruction.
机译:目的:研究营养支持+静脉化疗对结肠癌合并肠梗阻不全患者抗肿瘤免疫和癌细胞增殖的影响。方法:在密地分院接受治疗的结肠癌合并肠梗阻不全患者。选择2015年3月至2017年10月攀钢集团总医院,随机分为接受营养支持+ FOLFOX4静脉化疗的营养组和仅接受FOLFOX4静脉化疗的对照组,经过两个疗程的化疗。在化疗前和化疗后两个周期测定外周血中免疫细胞的含量和血清中免疫细胞因子的含量。结果:与化疗前同组比较,外周血Treg,Th9,Th17和Th22含量以及血清IL-4,IL-9,IL含量与化疗前同组。化疗后,营养组-10的TGF-β1,IL-17和IL-22含量显着降低,而外周血Treg,Th9,Th17和Th22含量以及血清IL-4,IL-9,IL-10,TGF化疗后对照组的-β1,IL-17和IL-22含量无明显变化,与化疗后各组比较,外周血Treg,Th9,Th17和Th22含量以及血清IL-4,IL- 9,营养组IL-10,TGF-β1,IL-17和IL-22含量明显低于对照组,CyclinD1,Bcl-2,USP22,VEGF和N-cadherin mRNA表达与对照组无明显差异。结论:营养支持+静脉化疗可改善抗肿瘤作用免疫反应,不影响结肠癌并发肠梗阻不全患者病灶中癌细胞的增殖。

著录项

  • 来源
    《海南医科大学学报(英文版)》 |2018年第13期|85-88|共4页
  • 作者

    Yu-Fang Xie; Jian-Feng Guo;

  • 作者单位

    Department of Cardiology, Midi Branch, Pangang Group General Hospital, Panzhihua 617063, Sichuan Province, China;

    Digestive System, Medical Oncology Department, Midi Branch, Pangang Group General Hospital, Panzhihua 617063, Sichuan Province, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号